KR100734995B1 - 마이코플라즈마 뉴모니아 검출용 항체 - Google Patents
마이코플라즈마 뉴모니아 검출용 항체 Download PDFInfo
- Publication number
- KR100734995B1 KR100734995B1 KR1020027009787A KR20027009787A KR100734995B1 KR 100734995 B1 KR100734995 B1 KR 100734995B1 KR 1020027009787 A KR1020027009787 A KR 1020027009787A KR 20027009787 A KR20027009787 A KR 20027009787A KR 100734995 B1 KR100734995 B1 KR 100734995B1
- Authority
- KR
- South Korea
- Prior art keywords
- antibody
- mycoplasma pneumoniae
- protein
- microorganism
- detecting
- Prior art date
Links
- 241000202934 Mycoplasma pneumoniae Species 0.000 title claims abstract description 67
- 244000005700 microbiome Species 0.000 claims abstract description 76
- 238000000034 method Methods 0.000 claims abstract description 74
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 48
- 238000001514 detection method Methods 0.000 claims abstract description 41
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 29
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 17
- 108010000605 Ribosomal Proteins Proteins 0.000 claims abstract description 11
- 102000002278 Ribosomal Proteins Human genes 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 108050000743 Ribosomal protein L7/L12 Proteins 0.000 claims description 45
- 102000008837 Ribosomal protein L7/L12 Human genes 0.000 claims description 41
- 108091007433 antigens Proteins 0.000 claims description 33
- 102000036639 antigens Human genes 0.000 claims description 33
- 239000000427 antigen Substances 0.000 claims description 30
- 102000004190 Enzymes Human genes 0.000 claims description 19
- 108090000790 Enzymes Proteins 0.000 claims description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 10
- 241000894007 species Species 0.000 claims description 10
- 108010037046 ribosomal protein L7-L12 Proteins 0.000 claims description 8
- 238000000746 purification Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 238000010353 genetic engineering Methods 0.000 claims description 4
- 230000002163 immunogen Effects 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 239000006166 lysate Substances 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 238000002955 isolation Methods 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 102100025643 60S ribosomal protein L12 Human genes 0.000 abstract description 5
- 101000575173 Homo sapiens 60S ribosomal protein L12 Proteins 0.000 abstract description 5
- 101000659995 Homo sapiens Ribosomal L1 domain-containing protein 1 Proteins 0.000 abstract description 5
- 206010035664 Pneumonia Diseases 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 210000004027 cell Anatomy 0.000 description 29
- 239000000243 solution Substances 0.000 description 27
- 235000018102 proteins Nutrition 0.000 description 25
- 239000006228 supernatant Substances 0.000 description 25
- 125000003275 alpha amino acid group Chemical group 0.000 description 20
- 108020004414 DNA Proteins 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- 239000000047 product Substances 0.000 description 14
- 108010070675 Glutathione transferase Proteins 0.000 description 13
- 102000005720 Glutathione transferase Human genes 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 13
- 239000000523 sample Substances 0.000 description 12
- 210000004408 hybridoma Anatomy 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 238000002965 ELISA Methods 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 102000013415 peroxidase activity proteins Human genes 0.000 description 7
- 108040007629 peroxidase activity proteins Proteins 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 239000012980 RPMI-1640 medium Substances 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 238000002405 diagnostic procedure Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 241000204003 Mycoplasmatales Species 0.000 description 5
- 239000013504 Triton X-100 Substances 0.000 description 5
- 229920004890 Triton X-100 Polymers 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 238000003018 immunoassay Methods 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 241000606768 Haemophilus influenzae Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 241000204031 Mycoplasma Species 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 231100000676 disease causative agent Toxicity 0.000 description 4
- 108020001507 fusion proteins Proteins 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 238000003317 immunochromatography Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 201000009906 Meningitis Diseases 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 239000007984 Tris EDTA buffer Substances 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102100035841 60S ribosomal protein L7 Human genes 0.000 description 2
- SQAMFSBCDWMGTD-UHFFFAOYSA-O CC(O)=[S+]C(C)=O.ON(C(CC1)=O)C1=O Chemical compound CC(O)=[S+]C(C)=O.ON(C(CC1)=O)C1=O SQAMFSBCDWMGTD-UHFFFAOYSA-O 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000853617 Homo sapiens 60S ribosomal protein L7 Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 108020004418 ribosomal RNA Proteins 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003757 Atypical pneumonia Diseases 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 101710181478 Envelope glycoprotein GP350 Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000495778 Escherichia faecalis Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000204051 Mycoplasma genitalium Species 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000588649 Neisseria lactamica Species 0.000 description 1
- 241000588645 Neisseria sicca Species 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000002725 anti-mycoplasma Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- BKHZIBWEHPHYAI-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol Chemical compound ClC(Cl)Cl.CC(C)CCO BKHZIBWEHPHYAI-UHFFFAOYSA-N 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56927—Chlamydia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1253—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56933—Mycoplasma
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
검출결과 (106 세포/ml) | |
엠. 뉴모니아 (M. pneumoniae) | + |
검출결과 (108 세포/ml) | |
엔. 메닌지타이즈 (N. meningitides) | - |
엔. 락타미카 (N. lactamica) | - |
엔. 뮤코사 (N. Mucosa) | - |
엔. 시카 (N. sicca) | - |
에이치. 인플루엔자 (H. influenzae) | - |
비. 카타르해리스 (B. catarrharis) | - |
엔. 고노르호에아 (N. gonorrhoeae) | - |
이. 콜라이 (E. coli) | - |
케이. 뉴모니아 (K. pneumoniae) | - |
+; 포지티브, -; 네가티브 |
검출결과 (108 세포/ml) | ||
엠. 뉴모니아 | + | |
에이치. 인플루엔자 | ATCC10211 | - |
이. 콜라이 | ATCC25922 | - |
이. 패칼리스 (E. faecalis) | ATCC19433 | - |
케이. 뉴모니아 | ATCC13883 | - |
엔. 고노르호에아 | IID821 | - |
엔. 락타미카 | ATCC23970 | - |
엔. 메닌지타이즈 | ATCC13090 | - |
피. 아에루기노사 (P. aeruginosa) | ATCC27853 | - |
그룹B 스트렙토코쿠스 (GroupB Streptococcus) | ATCC12386 | - |
에스. 아우레우스 (S. aureus) | ATCC25923 | - |
에스. 뉴모니아 (S. pneumoniae) | ATCC27336 | - |
에스. 피오게네스 (S. pyogenes) | ATCC19615 | - |
+; 포지티브, -; 네가티브 |
Claims (28)
- 마이코플라즈마 뉴모니아 (Mycoplasma pneumoniae)에 속하는 세균의 리보좀 단백질 L7/L12에 특이적으로 반응하는, 세균의 리보좀 단백질 L7/L12에 대한 항체이며, 해당 세균의 종 또는 속을 다른 종 또는 속으로부터 판별할 수 있는 항체.
- 삭제
- 제1항에 있어서, 항체가 모노크로날 또는 폴리크로날인 항체.
- 제1항에 있어서, 항체가 효소와 결합된 항체인 항체.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 제3항에 있어서, 항체가 효소와 결합된 항체인 항체.
- 제1항에 기재된 항체를 사용하는 것을 특징으로 하는, 마이코플라즈마 뉴모니아에 속하는 미생물의 검출 방법.
- 제3항에 기재된 항체를 사용하는 것을 특징으로 하는, 마이코플라즈마 뉴모니아에 속하는 미생물의 검출 방법.
- 제4항에 기재된 항체를 사용하는 것을 특징으로 하는, 마이코플라즈마 뉴모니아에 속하는 미생물의 검출 방법.
- 제10항에 기재된 항체를 사용하는 것을 특징으로 하는, 마이코플라즈마 뉴모니아에 속하는 미생물의 검출 방법.
- a) 검체를 용해액과 접촉시켜 미생물로부터 리보좀 단백질을 추출하는 단계, b) 추출한 검체를 포획 항체, 즉 제1항에 기재된 항체가 고체 표면 상에 고정된 항체와 접촉시킴으로써 리보좀 단백질과 포획 항체와의 사이에 항원 항체 복합체를 형성시키는 단계 및 c) 검출용 항체, 즉 제1항에 기재된 항체를 사용하여 항원 항체 복합체를 검출하는 단계를 포함하는, 검체 중의 마이코플라즈마 뉴모니아에 속하는 미생물의 검출 방법.
- a) 검체를 용해액과 접촉시켜 미생물로부터 리보좀 단백질을 추출하는 단계, b) 추출한 검체를 포획 항체, 즉 제3항에 기재된 항체가 고체 표면 상에 고정된 항체와 접촉시킴으로써 리보좀 단백질과 포획 항체와의 사이에 항원 항체 복합체를 형성시키는 단계 및 c) 검출용 항체, 즉 제3항에 기재된 항체를 사용하여 항원 항체 복합체를 검출하는 단계를 포함하는, 검체 중의 마이코플라즈마 뉴모니아에 속하는 미생물의 검출 방법.
- a) 검체를 용해액과 접촉시켜 미생물로부터 리보좀 단백질을 추출하는 단계, b) 추출한 검체를 포획 항체, 즉 제4항에 기재된 항체가 고체 표면 상에 고정된 항체와 접촉시킴으로써 리보좀 단백질과 포획 항체와의 사이에 항원 항체 복합체를 형성시키는 단계 및 c) 검출용 항체, 즉 제4항에 기재된 항체를 사용하여 항원 항체 복합체를 검출하는 단계를 포함하는, 검체 중의 마이코플라즈마 뉴모니아에 속하는 미생물의 검출 방법.
- a) 검체를 용해액과 접촉시켜 미생물로부터 리보좀 단백질을 추출하는 단계, b) 추출한 검체를 포획 항체, 즉 제10항에 기재된 항체가 고체 표면 상에 고정된 항체와 접촉시킴으로써 리보좀 단백질과 포획 항체와의 사이에 항원 항체 복합체를 형성시키는 단계 및 c) 검출용 항체, 즉 제10항에 기재된 항체를 사용하여 항원 항체 복합체를 검출하는 단계를 포함하는, 검체 중의 마이코플라즈마 뉴모니아에 속하는 미생물의 검출 방법.
- 제15항에 있어서, 검출용 항체가 효소와 결합된 항체이며, 항원 항체 복합체가 이 효소의 특이적 기질에 의해 검출되는 것임을 특징으로 하는 방법.
- 제16항에 있어서, 검출용 항체가 효소와 결합된 항체이며, 항원 항체 복합체가 이 효소의 특이적 기질에 의해 검출되는 것임을 특징으로 하는 방법.
- 제17항에 있어서, 검출용 항체가 효소와 결합된 항체이며, 항원 항체 복합체가 이 효소의 특이적 기질에 의해 검출되는 것임을 특징으로 하는 방법.
- 제18항에 있어서, 검출용 항체가 효소와 결합된 항체이며, 항원 항체 복합체가 이 효소의 특이적 기질에 의해 검출되는 것임을 특징으로 하는 방법.
- 제1항에 기재된 항체를 사용하는 것을 특징으로 하는, 마이코플라즈마 뉴모니아에 속하는 미생물의 검출용 시약 키트.
- 제3항에 기재된 항체를 사용하는 것을 특징으로 하는, 마이코플라즈마 뉴모니아에 속하는 미생물의 검출용 시약 키트.
- 제4항에 기재된 항체를 사용하는 것을 특징으로 하는, 마이코플라즈마 뉴모니아에 속하는 미생물의 검출용 시약 키트.
- 제10항에 기재된 항체를 사용하는 것을 특징으로 하는, 마이코플라즈마 뉴모니아에 속하는 미생물의 검출용 시약 키트.
- 유전자 조작 방법에 의해 또는 미생물로부터의 단리 정제에 의해 얻어진 마이코플라즈마 뉴모니아에 속하는 미생물의 리보좀 단백질 L7/L12 단백질, 그의 부분 펩티드, 또는 그의 부분 펩티드에 상당하는 합성 펩티드를 면역원으로 하는 것을 특징으로 하는, 제1항에 기재된 항체의 제조 방법.
- 유전자 조작 방법에 의해 또는 미생물로부터의 단리 정제에 의해 얻어진 마이코플라즈마 뉴모니아에 속하는 미생물의 리보좀 단백질 L7/L12 단백질, 그의 부분 펩티드, 또는 그의 부분 펩티드에 상당하는 합성 펩티드를 면역원으로 하는 것을 특징으로 하는, 제3항에 기재된 항체의 제조 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000062729 | 2000-01-31 | ||
JPJP-P-2000-00062729 | 2000-01-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020073192A KR20020073192A (ko) | 2002-09-19 |
KR100734995B1 true KR100734995B1 (ko) | 2007-07-04 |
Family
ID=18582698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020027009787A KR100734995B1 (ko) | 2000-01-31 | 2001-01-31 | 마이코플라즈마 뉴모니아 검출용 항체 |
Country Status (7)
Country | Link |
---|---|
JP (2) | JP5331285B2 (ko) |
KR (1) | KR100734995B1 (ko) |
CN (1) | CN100516210C (ko) |
AU (1) | AU2001230532A1 (ko) |
CA (1) | CA2398469C (ko) |
TW (1) | TWI282368B (ko) |
WO (1) | WO2001057199A1 (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004201605A (ja) * | 2002-12-26 | 2004-07-22 | Asahi Kasei Corp | レジオネラ属菌リボソームl7/l12タンパク質をコードするdna |
KR100905066B1 (ko) * | 2007-12-04 | 2009-06-30 | 주식회사 바이오랜드 | 마이코플라즈마 뉴모니아성 폐렴 진단을 위한 재조합단백질 및 이를 이용한 진단 키트 |
JP5458344B2 (ja) * | 2008-01-30 | 2014-04-02 | 旭化成株式会社 | 抗体固定化担体 |
JP5712140B2 (ja) * | 2009-12-04 | 2015-05-07 | 株式会社Lsiメディエンス | マイコプラズマ・ニューモニエ及び/又はマイコプラズマ・ジェニタリウムに属する微生物を検出する方法 |
JP6150559B2 (ja) * | 2013-02-28 | 2017-06-21 | 旭化成株式会社 | マイコプラズマ・ニューモニアの検出方法 |
US10174103B2 (en) | 2013-08-23 | 2019-01-08 | Tauns Co., Ltd. | Mycoplasma pneumoniae immunological detection method and kit |
JP2016031353A (ja) | 2014-07-30 | 2016-03-07 | 株式会社 富山研究所 | 肺炎マイコプラズマ検出試薬及びその用途 |
JP7402659B2 (ja) * | 2019-11-01 | 2023-12-21 | 旭化成株式会社 | 検体中の肺炎マイコプラズマを検出するための抗体、並びに斯かる抗体を用いて肺炎マイコプラズマを検出するための方法、試薬、及びキット |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7068587A (en) * | 1986-03-27 | 1987-10-01 | Cetus Corporation | Monoclonal antibody immunoblot assay for antigens |
JP3592709B2 (ja) * | 1990-09-11 | 2004-11-24 | インスティテュート・フォー・チャイルド・ヘルス・リサーチ | ダーマトファゴイデス(家塵ダニ)のアレルゲンのクローニングおよびシークエンシング |
AU3355095A (en) * | 1994-09-02 | 1996-03-27 | Meiji Milk Products Company Limited | Diagnostic drug for chlamydia infection |
JPH0931097A (ja) * | 1995-07-24 | 1997-02-04 | Yuka Medeiasu:Kk | クラミジア・トラコマティス抗体の測定法 |
-
2001
- 2001-01-31 CN CNB018057284A patent/CN100516210C/zh not_active Expired - Lifetime
- 2001-01-31 TW TW090101940A patent/TWI282368B/zh not_active IP Right Cessation
- 2001-01-31 JP JP2001558014A patent/JP5331285B2/ja not_active Expired - Lifetime
- 2001-01-31 AU AU2001230532A patent/AU2001230532A1/en not_active Abandoned
- 2001-01-31 KR KR1020027009787A patent/KR100734995B1/ko active IP Right Grant
- 2001-01-31 CA CA002398469A patent/CA2398469C/en not_active Expired - Lifetime
- 2001-01-31 WO PCT/JP2001/000626 patent/WO2001057199A1/ja active Application Filing
-
2011
- 2011-09-08 JP JP2011196201A patent/JP2012006968A/ja active Pending
Non-Patent Citations (2)
Title |
---|
Genbank accession No. AAB95951 |
Microbiology, vol. 143(1), 55-61 |
Also Published As
Publication number | Publication date |
---|---|
TWI282368B (en) | 2007-06-11 |
JP5331285B2 (ja) | 2013-10-30 |
CA2398469A1 (en) | 2001-08-09 |
JP2012006968A (ja) | 2012-01-12 |
KR20020073192A (ko) | 2002-09-19 |
AU2001230532A1 (en) | 2001-08-14 |
WO2001057199A1 (fr) | 2001-08-09 |
CN1406279A (zh) | 2003-03-26 |
CN100516210C (zh) | 2009-07-22 |
CA2398469C (en) | 2009-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1104772B1 (en) | Anti-l7/l12 antibody for detecting bacteria | |
JP2012006968A (ja) | マイコプラズマ・ニューモニア検出用抗体 | |
JP5712140B2 (ja) | マイコプラズマ・ニューモニエ及び/又はマイコプラズマ・ジェニタリウムに属する微生物を検出する方法 | |
US7374888B2 (en) | Methods for detecting B. anthracis infection | |
US20090269789A1 (en) | Antibodies for detecting microorganisms | |
JP2012017334A (ja) | クラミジア・ニューモニア検出用抗体 | |
US7393647B2 (en) | Methods for detecting B. anthracis infection | |
JP2011160809A (ja) | ウィップル病の診断 | |
JP5351367B2 (ja) | クラミジア・トラコマチス検出用抗体 | |
JPWO2020111272A1 (ja) | 細菌感染による急性副鼻腔炎の起炎菌の検出方法 | |
RU2575075C2 (ru) | Способ обнаружения микроорганизмов, принадлежащих виду mycoplasma pneumoniae и/или mycoplasma genitalium | |
JP3914914B2 (ja) | ストレプトコッカス・ピオゲネス菌に起因する感染症の診断用プローブ | |
JP3914916B2 (ja) | ストレプトコッカス・ピオゲネス菌に起因する感染症の診断用プローブ | |
JP3914915B2 (ja) | ストレプトコッカス・ピオゲネス菌に起因する感染症の診断用プローブ | |
WO2004106886A2 (en) | Methods for detecting b. anthracis infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
FPAY | Annual fee payment |
Payment date: 20130531 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140603 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150601 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160527 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180619 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190619 Year of fee payment: 13 |